Incyte (INCY) EBT (2010 - 2026)
Incyte (INCY) posted EBT of $343.6 million for Q1 2026, down 11.88% on a QoQ basis from $389.9 million in Q4 2025, and up 46.72% year-over-year from $234.2 million in Q1 2025.
Incyte (INCY) EBT (2010 - 2026) Analysis & Trends
Incyte's EBT history runs 17 years deep, the most recent figure standing at $343.6 million for Q1 2026.
- Quarterly EBT rose 46.72% year-over-year to $343.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.8 billion (up 463.74% YoY) and the FY2025 annual result came in at $1.7 billion, up 425.68% from the prior year.
- EBT was $343.6 million for Q1 2026 at Incyte, down from $389.9 million in the prior quarter.
- Across five years, EBT topped out at $558.0 million in Q2 2025 and bottomed at -$389.8 million in Q2 2024.
- A 5-year average of $216.9 million and a median of $234.2 million in 2025 frame the typical range for EBT.
- Peak annual rise in EBT reached 355.41% in 2024, while the deepest fall reached 240.41% in 2024.
- Incyte's EBT stood at $80.6 million in 2022, then soared by 236.11% to $271.0 million in 2023, then climbed by 15.78% to $313.7 million in 2024, then increased by 24.29% to $389.9 million in 2025, then fell by 11.88% to $343.6 million in 2026.
- Business Quant data shows INCY's EBT at $343.6 million in Q1 2026, $389.9 million in Q4 2025, and $482.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -36.97 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -15.31 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 259.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 1.25 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 831.20 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | -26.94 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 438.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -453.82 Mn |
| 10 | Incyte | 23.47 Bn | 19.46 Bn | 1.17 Bn | 343.60 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 343.60 Mn |
| Dec 31, 2025 | 389.94 Mn |
| Sep 30, 2025 | 482.31 Mn |
| Jun 30, 2025 | 558.01 Mn |
| Mar 31, 2025 | 234.19 Mn |
| Dec 31, 2024 | 313.72 Mn |
| Sep 30, 2024 | 156.52 Mn |
| Jun 30, 2024 | -389.78 Mn |
| Mar 31, 2024 | 236.16 Mn |
| Dec 31, 2023 | 270.96 Mn |
| Sep 30, 2023 | 233.80 Mn |
| Jun 30, 2023 | 277.60 Mn |
| Mar 31, 2023 | 51.86 Mn |
| Dec 31, 2022 | 80.62 Mn |
| Sep 30, 2022 | 148.59 Mn |
| Jun 30, 2022 | 229.38 Mn |
| Mar 31, 2022 | 70.54 Mn |
| Dec 31, 2021 | 120.02 Mn |
| Sep 30, 2021 | 209.47 Mn |
| Jun 30, 2021 | 171.63 Mn |